{"id":"https://openalex.org/W4200310043","doi":"https://doi.org/10.1158/1078-0432.ccr-21-2272","title":"Trilaciclib Prior to Chemotherapy in Patients with Metastatic Triple-Negative Breast Cancer: Final Efficacy and Subgroup Analysis from a Randomized Phase II Study","display_name":"Trilaciclib Prior to Chemotherapy in Patients with Metastatic Triple-Negative Breast Cancer: Final Efficacy and Subgroup Analysis from a Randomized Phase II Study","alternate_titles":[],"publication_year":2021,"publication_date":"2021-12-06","ids":{"openalex":"https://openalex.org/W4200310043","doi":"https://doi.org/10.1158/1078-0432.ccr-21-2272","pmid":"https://pubmed.ncbi.nlm.nih.gov/34887261","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9377748"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-21-2272","doi":"https://doi.org/10.1158/1078-0432.ccr-21-2272","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-21-2272","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4200310043"],"child_works_count":2,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1158/1078-0432.ccr-21-2272","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022891785","display_name":"Antoinette R. Tan","orcid":"https://orcid.org/0000-0002-7895-7000","observed_orcids":["https://orcid.org/0000-0002-7895-7000"]},"institutions":[{"id":"https://openalex.org/I4210100342","display_name":"Levine Cancer Institute","ror":"https://ror.org/0174nh398","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334069289","https://openalex.org/I4210100342"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/conceptualization","display_name":"Conceptualization"},{"id":"https://openalex.org/contributor-roles/investigation","display_name":"Investigation"},{"id":"https://openalex.org/contributor-roles/methodology","display_name":"Methodology"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Antoinette R. Tan","raw_affiliation_strings":["1Levine Cancer Institute, Atrium Health, Charlotte, North Carolina"],"raw_orcid":"https://orcid.org/0000-0002-7895-7000","affiliations":[{"raw_affiliation_string":"1Levine Cancer Institute, Atrium Health, Charlotte, North Carolina","institution_ids":["https://openalex.org/I4210100342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016843577","display_name":"Gail Shaw Wright","orcid":"https://orcid.org/0000-0002-3795-7573","observed_orcids":["https://orcid.org/0000-0002-3795-7573"]},"institutions":[{"id":"https://openalex.org/I4210118420","display_name":"Florida Cancer Specialists & Research Institute","ror":"https://ror.org/02px37122","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210118420"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/investigation","display_name":"Investigation"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Gail S. Wright","raw_affiliation_strings":["2Florida Cancer Specialists and Research Institute, New Port Richey, Florida"],"raw_orcid":"https://orcid.org/0000-0002-3795-7573","affiliations":[{"raw_affiliation_string":"2Florida Cancer Specialists and Research Institute, New Port Richey, Florida","institution_ids":["https://openalex.org/I4210118420"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114045876","display_name":"Anu R. Thummala","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163348","display_name":"Comprehensive Cancer Centers of Nevada","ror":"https://ror.org/05etxbz89","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210163348"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/investigation","display_name":"Investigation"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Anu R. Thummala","raw_affiliation_strings":["3Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada","institution_ids":["https://openalex.org/I4210163348"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110975690","display_name":"Michael A. Danso","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088931","display_name":"Virginia Oncology Associates","ror":"https://ror.org/009yyqs39","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210088931"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/investigation","display_name":"Investigation"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Michael A. Danso","raw_affiliation_strings":["4Virginia Oncology Associates, Norfolk, Virginia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Virginia Oncology Associates, Norfolk, Virginia","institution_ids":["https://openalex.org/I4210088931"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072986024","display_name":"LAZAR S. POPOVIC","orcid":"https://orcid.org/0000-0002-3278-6875","observed_orcids":["https://orcid.org/0000-0002-3278-6875"]},"institutions":[{"id":"https://openalex.org/I170726198","display_name":"University of Novi Sad","ror":"https://ror.org/00xa57a59","country_code":"RS","type":"education","lineage":["https://openalex.org/I170726198"]},{"id":"https://openalex.org/I4210106714","display_name":"Oncology Institute of Vojvodina","ror":"https://ror.org/0194xa029","country_code":"RS","type":"facility","lineage":["https://openalex.org/I4210106714"]}],"countries":["RS"],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/investigation","display_name":"Investigation"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Lazar Popovic","raw_affiliation_strings":["5Oncology Institute of Vojvodina, University of Novi Sad, Novi Sad, Serbia"],"raw_orcid":"https://orcid.org/0000-0002-3278-6875","affiliations":[{"raw_affiliation_string":"5Oncology Institute of Vojvodina, University of Novi Sad, Novi Sad, Serbia","institution_ids":["https://openalex.org/I170726198","https://openalex.org/I4210106714"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038208006","display_name":"Timothy Pluard","orcid":"https://orcid.org/0000-0002-3640-3077","observed_orcids":["https://orcid.org/0000-0002-3640-3077"]},"institutions":[{"id":"https://openalex.org/I4210137478","display_name":"Saint Luke's Hospital","ror":"https://ror.org/04k1cm432","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1339091601","https://openalex.org/I4210137478","https://openalex.org/I75421653"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/investigation","display_name":"Investigation"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Timothy J. Pluard","raw_affiliation_strings":["6Saint Luke's Cancer Institute, Kansas City, Missouri"],"raw_orcid":"https://orcid.org/0000-0002-3640-3077","affiliations":[{"raw_affiliation_string":"6Saint Luke's Cancer Institute, Kansas City, Missouri","institution_ids":["https://openalex.org/I4210137478"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059240684","display_name":"Hyo Sook Han","orcid":"https://orcid.org/0000-0002-0072-0257","observed_orcids":["https://orcid.org/0000-0002-0072-0257"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/investigation","display_name":"Investigation"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Hyo S. Han","raw_affiliation_strings":["7H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida"],"raw_orcid":"https://orcid.org/0000-0002-0072-0257","affiliations":[{"raw_affiliation_string":"7H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053068607","display_name":"\u017deljko Vojnovi\u0107","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148069","display_name":"Op\u0107a Bolnica Vara\u017edin","ror":"https://ror.org/056bmw021","country_code":"HR","type":"healthcare","lineage":["https://openalex.org/I4210148069"]}],"countries":["HR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"\u017deljko Vojnovi\u0107","raw_affiliation_strings":["8Vara\u017edin General Hospital, Vara\u017edin, Croatia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8Vara\u017edin General Hospital, Vara\u017edin, Croatia","institution_ids":["https://openalex.org/I4210148069"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088262878","display_name":"Nikola Vasev","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267927","display_name":"University Clinic for Radiotherapy and Oncology","ror":"https://ror.org/052m9k994","country_code":"MK","type":"education","lineage":["https://openalex.org/I4405267927"]}],"countries":["MK"],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/investigation","display_name":"Investigation"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Nikola Vasev","raw_affiliation_strings":["9University Clinic of Radiotherapy and Oncology, Skopje, North Macedonia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"9University Clinic of Radiotherapy and Oncology, Skopje, North Macedonia","institution_ids":["https://openalex.org/I4405267927"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101562260","display_name":"Ling Ma","orcid":"https://orcid.org/0000-0003-2638-3065","observed_orcids":["https://orcid.org/0000-0003-2638-3065"]},"institutions":[{"id":"https://openalex.org/I4210140702","display_name":"Rocky Mountain Cancer Centers","ror":"https://ror.org/03ynhs115","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210140702"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/investigation","display_name":"Investigation"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Ling Ma","raw_affiliation_strings":["10Rocky Mountain Cancer Centers, Lakewood, Colorado"],"raw_orcid":"https://orcid.org/0000-0003-2638-3065","affiliations":[{"raw_affiliation_string":"10Rocky Mountain Cancer Centers, Lakewood, Colorado","institution_ids":["https://openalex.org/I4210140702"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015961133","display_name":"Donald Richards","orcid":"https://orcid.org/0000-0002-2254-4514","observed_orcids":["https://orcid.org/0000-0002-2254-4514","https://orcid.org/0009-0005-8381-6033"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/investigation","display_name":"Investigation"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Donald A. Richards","raw_affiliation_strings":["11Texas Oncology-Tyler, US Oncology Research, Tyler, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"11Texas Oncology-Tyler, US Oncology Research, Tyler, Texas","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086433204","display_name":"Sharon T. Wilks","orcid":"https://orcid.org/0000-0003-2004-4273","observed_orcids":["https://orcid.org/0000-0003-2004-4273"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/investigation","display_name":"Investigation"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Sharon T. Wilks","raw_affiliation_strings":["12Texas Oncology-San Antonio, US Oncology Research, San Antonio, Texas"],"raw_orcid":"https://orcid.org/0000-0003-2004-4273","affiliations":[{"raw_affiliation_string":"12Texas Oncology-San Antonio, US Oncology Research, San Antonio, Texas","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025844960","display_name":"Du\u0161an Milenkovi\u0107","orcid":"https://orcid.org/0000-0002-7434-9534","observed_orcids":["https://orcid.org/0000-0002-7434-9534"]},"institutions":[{"id":"https://openalex.org/I4210111767","display_name":"Klini\u010dki centar Ni\u0161","ror":"https://ror.org/01strh679","country_code":"RS","type":"healthcare","lineage":["https://openalex.org/I4210111767"]}],"countries":["RS"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Du\u0161an Milenkovi\u0107","raw_affiliation_strings":["13Clinical Center Ni\u0161, Ni\u0161, Serbia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"13Clinical Center Ni\u0161, Ni\u0161, Serbia","institution_ids":["https://openalex.org/I4210111767"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101948840","display_name":"Jie Xiao","orcid":"https://orcid.org/0009-0002-2261-5682","observed_orcids":["https://orcid.org/0009-0002-2261-5682","https://orcid.org/0009-0005-1911-9794"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/formal-analysis","display_name":"Formal analysis"},{"id":"https://openalex.org/contributor-roles/methodology","display_name":"Methodology"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Jie Xiao","raw_affiliation_strings":["14G1 Therapeutics, Inc., Research Triangle Park, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"14G1 Therapeutics, Inc., Research Triangle Park, North Carolina","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058971478","display_name":"Jessica A. Sorrentino","orcid":"https://orcid.org/0000-0002-3985-2783","observed_orcids":["https://orcid.org/0000-0002-3985-2783"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/conceptualization","display_name":"Conceptualization"},{"id":"https://openalex.org/contributor-roles/formal-analysis","display_name":"Formal analysis"},{"id":"https://openalex.org/contributor-roles/investigation","display_name":"Investigation"},{"id":"https://openalex.org/contributor-roles/methodology","display_name":"Methodology"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Jessica Sorrentino","raw_affiliation_strings":["14G1 Therapeutics, Inc., Research Triangle Park, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"14G1 Therapeutics, Inc., Research Triangle Park, North Carolina","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003842236","display_name":"Janet K. Horton","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/conceptualization","display_name":"Conceptualization"},{"id":"https://openalex.org/contributor-roles/formal-analysis","display_name":"Formal analysis"},{"id":"https://openalex.org/contributor-roles/methodology","display_name":"Methodology"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Janet Horton","raw_affiliation_strings":["14G1 Therapeutics, Inc., Research Triangle Park, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"14G1 Therapeutics, Inc., Research Triangle Park, North Carolina","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071432873","display_name":"Joyce O\u2019Shaughnessy","orcid":"https://orcid.org/0000-0002-2955-5523","observed_orcids":["https://orcid.org/0000-0002-2955-5523","https://orcid.org/0000-0001-6764-2807"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Joyce O'Shaughnessy","raw_affiliation_strings":["15Texas Oncology\u2014Baylor Charles A. Sammons Cancer Center, US Oncology Research, Dallas, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"15Texas Oncology\u2014Baylor Charles A. Sammons Cancer Center, US Oncology Research, Dallas, Texas","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":12,"corresponding_author_ids":["https://openalex.org/A5022891785"],"corresponding_institution_ids":["https://openalex.org/I4210100342"],"apc_list":null,"apc_paid":null,"fwci":2.4837,"has_fulltext":true,"cited_by_count":48,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.92504008,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":99},"biblio":{"volume":"28","issue":"4","first_page":"629","last_page":"636"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.00430000014603138,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trilaciclib","display_name":"trilaciclib","score":1.0},{"id":"https://openalex.org/keywords/metastatic-triple-negative-breast-cancer","display_name":"metastatic triple-negative breast cancer","score":0.9430000185966492},{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":0.8650000095367432},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.5870000123977661},{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.9520000219345093},{"id":"https://openalex.org/keywords/immune-signatures","display_name":"immune signatures","score":0.5699999928474426},{"id":"https://openalex.org/keywords/t-cell-receptor-cdr3","display_name":"T cell receptor CDR3","score":0.7850000262260437},{"id":"https://openalex.org/keywords/t-cell-activation","display_name":"T cell activation","score":0.9769999980926514},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.531000018119812},{"id":"https://openalex.org/keywords/antitumor-efficacy","display_name":"antitumor efficacy","score":0.5379999876022339}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6636497974395752},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6430808901786804},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.6420325636863708},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6146901845932007},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.593245267868042},{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.5811879634857178},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5434936881065369},{"id":"https://openalex.org/C187960798","wikidata":"https://www.wikidata.org/wiki/Q7631152","display_name":"Subgroup analysis","level":3,"score":0.5420629978179932},{"id":"https://openalex.org/C2992734768","wikidata":"https://www.wikidata.org/wiki/Q48964","display_name":"Triple negative","level":4,"score":0.5272228717803955},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4401804208755493},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.22830483317375183}],"mesh":[{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D064726","descriptor_name":"Triple Negative Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1158/1078-0432.ccr-21-2272","doi":"https://doi.org/10.1158/1078-0432.ccr-21-2272","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-21-2272","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9377748","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9377748/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9377748/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin Cancer Res","raw_type":"Text"},{"id":"pmid:34887261","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34887261","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Clinical Trial, Phase II"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.ccr-21-2272","doi":"https://doi.org/10.1158/1078-0432.ccr-21-2272","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-21-2272","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320319266","display_name":"G1 Therapeutics","ror":"https://ror.org/048389405"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4200310043.pdf","grobid_xml":"https://content.openalex.org/works/W4200310043.grobid-xml"},"referenced_works_count":38,"referenced_works":["https://openalex.org/W2044702943","https://openalex.org/W2055164947","https://openalex.org/W2087189381","https://openalex.org/W2119878357","https://openalex.org/W2131682431","https://openalex.org/W2132619562","https://openalex.org/W2134539328","https://openalex.org/W2170602872","https://openalex.org/W2172358623","https://openalex.org/W2268588237","https://openalex.org/W2282026089","https://openalex.org/W2430731787","https://openalex.org/W2560367415","https://openalex.org/W2607761262","https://openalex.org/W2625001374","https://openalex.org/W2655262992","https://openalex.org/W2750328162","https://openalex.org/W2766016994","https://openalex.org/W2769376007","https://openalex.org/W2796207838","https://openalex.org/W2802392118","https://openalex.org/W2809138029","https://openalex.org/W2883670730","https://openalex.org/W2911718257","https://openalex.org/W2917414890","https://openalex.org/W2935187964","https://openalex.org/W2947477779","https://openalex.org/W2970740914","https://openalex.org/W2977211443","https://openalex.org/W3013242650","https://openalex.org/W3034875145","https://openalex.org/W3081561806","https://openalex.org/W3090036675","https://openalex.org/W3095826473","https://openalex.org/W3109853980","https://openalex.org/W3115102504","https://openalex.org/W3173705400","https://openalex.org/W4301159569"],"related_works":["https://openalex.org/W3129749107","https://openalex.org/W4383482873","https://openalex.org/W4296643044","https://openalex.org/W3212699510","https://openalex.org/W4379285788","https://openalex.org/W4396588106","https://openalex.org/W4362595416","https://openalex.org/W2977663305","https://openalex.org/W3167666502","https://openalex.org/W4322775277"],"abstract_inverted_index":{"PURPOSE:":[0],"We":[1],"report":[2],"final":[3],"antitumor":[4,228],"efficacy":[5],"results":[6],"from":[7],"a":[8],"phase":[9],"II":[10],"study":[11],"of":[12,92,123,186,202],"trilaciclib,":[13],"an":[14],"intravenous":[15],"cyclin-dependent":[16],"kinase":[17],"4/6":[18],"(CDK4/6)":[19],"inhibitor,":[20],"administered":[21],"prior":[22,56,74,196,224],"to":[23,43,57,75,88,116,197,225],"gemcitabine":[24],"plus":[25],"carboplatin":[26],"(GCb)":[27],"in":[28,141,146,157,169,209,217,233,237,242],"patients":[29,218],"with":[30,230],"metastatic":[31],"triple-negative":[32],"breast":[33],"cancer":[34,187],"(NCT02978716).":[35],"PATIENTS":[36],"AND":[37],"METHODS:":[38],"Patients":[39],"were":[40,85,112,183],"randomized":[41],"(1:1:1)":[42],"group":[44,53,66,142,147,158],"1":[45,95],"[GCb":[46],"(days":[47,59,69,77],"1,":[48,60,70,143],"8);":[49,61],"n":[50,62,80],"=":[51,63,81,150,153,161,164,176],"34],":[52],"2":[54,148,171],"[trilaciclib":[55,68],"GCb":[58,76,198,226],"33],":[64],"or":[65],"3":[67,159,173],"8)":[71],"and":[72,98,114,119,130,166,172,191,240],"trilaciclib":[73,195,223],"2,":[78],"9);":[79],"35].":[82],"Subgroup":[83],"analyses":[84],"performed":[86],"according":[87],"CDK4/6":[89,188],"dependence,":[90],"level":[91],"programmed":[93],"death-ligand":[94],"(PD-L1)":[96],"expression,":[97],"RNA-based":[99],"immune":[100,192],"signatures":[101],"using":[102],"proportional":[103],"hazards":[104],"regression.":[105],"T-cell":[106,213,243],"receptor":[107],"(TCR)":[108],"\u03b2":[109],"CDR3":[110,127],"regions":[111],"amplified":[113],"sequenced":[115],"identify,":[117],"quantify,":[118],"compare":[120],"the":[121,210],"abundance":[122],"each":[124],"unique":[125],"TCR\u03b2":[126],"at":[128],"baseline":[129],"on":[131],"treatment.":[132],"RESULTS:":[133],"Median":[134],"overall":[135],"survival":[136],"(OS)":[137],"was":[138,215],"12.6":[139],"months":[140,156,168],"not":[144],"reached":[145],"(HR":[149,160,175],"0.31;":[151],"P":[152,163,178],"0.0016),":[154],"17.8":[155],"0.40;":[162],"0.0004),":[165],"19.8":[167],"groups":[170],"combined":[174],"0.37;":[177],"<":[179],"0.0001).":[180],"Efficacy":[181,235],"outcomes":[182,236],"comparable":[184],"regardless":[185],"dependence":[189],"status":[190,204],"signatures.":[193],"Administering":[194,222],"prolonged":[199],"OS":[200],"irrespective":[201],"PD-L1":[203],"but":[205],"had":[206],"greater":[207],"benefit":[208],"PD-L1-positive":[211],"population.":[212],"activation":[214,244],"enhanced":[216,227],"receiving":[219],"trilaciclib.":[220],"CONCLUSIONS:":[221],"efficacy,":[229],"significant":[231],"improvements":[232,247],"OS.":[234],"immunologic":[238,252],"subgroups":[239],"enhancements":[241],"suggest":[245],"these":[246],"may":[248],"be":[249],"mediated":[250],"via":[251],"mechanisms.":[253]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4200310043","counts_by_year":[{"year":2026,"cited_by_count":9},{"year":2025,"cited_by_count":12},{"year":2024,"cited_by_count":10},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":7}],"updated_date":"2026-11-22T12:46:00.618207","created_date":"2021-12-31T00:00:00"}
